BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Batroxobin

Below is an extended Batroxobin research listing. Click here to return to the Batroxobin main in depth entry.

Recent Publications on Batroxobin:

Percutaneous injection therapy for blunt splenic trauma guided by contrast-enhanced ultrasonography. 1st October, 2008
Department of Ultrasound, Chinese People's Liberation Army General
Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
The activity of plasmin plays a critical role in the development of...
Direct Link
30th August, 2008
Department of Immunology, Mie University Graduate School of Medicine,
Portal vein thrombosis as the first sign of nephrotic syndrome.
BACKGROUND: A 52-year-old man presented to hospital having experienced...
Direct Link
1st August, 2008
Division of Nephrology at Changzheng Hospital, Second Military Medical
Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction.
We assumed that argatroban, a direct thrombin inhibitor, has a strong...
Direct Link
18th July, 2008
Institut fur Klinische Chemie und Laboratoriumsdiagnostik,
Effect of hemocoagulase for prevention of pulmonary hemorrhage in critical newborns on mechanical ventilation: a randomized controlled trial. 11th July, 2008
Department of Pediatrics, Research Institute of Surgery and Daping
Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
The first step in the activation of plasma factor XIII (FXIII) is the...
Direct Link
28th June, 2008
University of Debrecen, Medical and Health Science Center, Clinical
GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans.
Mass spectrometry is the main analytical technique currently used to...
Direct Link
24th June, 2008
Division of Molecular Biosciences, Imperial College London, London SW72AZ,
Platelet-rich plasma and platelet gel preparation using Plateltex.
BACKGROUND: The platelet gel is made by embedding concentrate platelets...
Direct Link
1st May, 2008
Blood Transfusion Centre and Biotechnology Laboratory, Ospedale SS Antonio
B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
BACKGROUND: Fibrin polymerization is mediated by interactions between...
Direct Link
9th January, 2008
Laboratory of Clinical Chemistry, Department of Biomedical Laboratory
Which knobs fit into which holes in fibrin polymerization?
BACKGROUND: Fibrin polymerization is mediated by interactions between...
Direct Link
9th January, 2008
Department of Cell and Developmental Biology, University of Pennsylvania
Role of 'B-b' knob-hole interactions in fibrin binding to adsorbed fibrinogen.
BACKGROUND: The formation of a fibrin clot is supported by multiple...
Direct Link
9th January, 2008
Department of Chemistry, University of North Carolina, Chapel Hill, NC
Identification and characterization of Harobin, a novel fibrino(geno)lytic serine protease from a sea snake (Lapemis hardwickii).
A gene encoding a novel serine protease designated as Harobin is cloned...
Direct Link
19th August, 2007
National Key Laboratory of Protein Engineering, LSC, Peking University,
Treatment of sudden sensorineural hearing loss: I. A systematic review.
OBJECTIVE: To identify, evaluate, and review randomized controlled trials...
Direct Link
20th July, 2007
Department of Otolaryngology, University of Ottawa, Ottawa, Ontario,
[Recombinant batroxobin expressed highly in Pichia pastoris] 21st June, 2007
Institute of Bioengineering, Academy of Military Medical Science, Beijing
Probing the gamma2 calcium-binding site: studies with gammaD298,301A fibrinogen reveal changes in the gamma294-301 loop that alter the integrity of the "a" polymerization site.
To determine the significance of the gamma2 calcium-binding site in fibrin...
Direct Link
21st June, 2007
Department of Chemistry, University of North Carolina, Chapel Hill, North
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional